DrugPatentWatch Database Preview

Terazosin hydrochloride - Generic Drug Details

What are the generic drug sources for terazosin hydrochloride and what is the scope of terazosin hydrochloride patent protection?

Terazosin hydrochloride is the generic ingredient in two branded drugs marketed by Abbott, Apotex, Ivax Sub Teva Pharms, Jubilant Cadista, Mylan Pharms Inc, Mylan Technologies, Ranbaxy Labs Ltd, Sandoz, and Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride. Twenty-four suppliers are listed for this compound.

Summary for terazosin hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	9
NDAs:	14
Drug Master File Entries:	24
Suppliers / Packagers:	24
Bulk Api Vendors:	59
Clinical Trials:	17
Patent Applications:	1,190
Formulation / Manufacturing:	see details
DailyMed Link:	terazosin hydrochloride at DailyMed

Pharmacology for terazosin hydrochloride

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Synonyms for terazosin hydrochloride

(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone hydrochloride
074T088
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine hydrochloride
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine Hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride
141269-45-6
2[4-(Tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline hydrochloride
4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride
6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride
63074-08-8
63590-64-7 (Parent)
AB1009460
AB2000463
Abbott-45975
AC-2074
AC1L2BPY
AK307521
AKOS007930686
AN-14324
BB_SC-1129
C19H25N5O4.HCl
CAS-63074-08-8
CCG-220751
CHEMBL1256665
DB-018541
DSSTox_CID_25493
DSSTox_GSID_45493
DSSTox_RID_80913
DTXSID7045493
EU-0101138
FT-0605647
HMS1570G04
Hytrin
I06-0651
IWSWDOUXSCRCKW-UHFFFAOYSA-N
KS-00000JKM
LP01138
LS-110235
MFCD00467965
MLS000040261
MLS001077301
MLS001305722
MolPort-003-666-790
NCGC00016026-10
NCGC00016903-01
NCGC00094404-01
NCGC00094404-02
NE45355
NSC-759168
NSC759168
Opera_ID_398
Pharmakon1600-01505576
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-,monohydrochloride
Prestwick_146
s4679
SCHEMBL41545
SMR000044015
T 4680
Terazosin HCl
TERAZOSIN HYDROCHLORIDE (anhydrous)
Terazosin hydrochloride anhydrous
Terazosin hydrochloride, >=98% (TLC), powder
Terazosin monohydrochloride anhydrous
terazosine hydrochloride
terazosinhydrochloride
Tetrazosin hydrochloride
TL8004930
Tox21_110674
Tox21_110674_1
TR-037527
TRA0127916
V1531
VA11840
Vasocard
Zayasel

US Patents and Regulatory Information for terazosin hydrochloride

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	TABLET;ORAL	074446-003	May 18, 2000		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ranbaxy Labs Ltd	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	CAPSULE;ORAL	076021-001	Aug 22, 2002		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sandoz	TERAZOSIN HYDROCHLORIDE	terazosin hydrochloride	CAPSULE;ORAL	075667-003	Jul 28, 2000		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for terazosin hydrochloride

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987	➤ Sign Up	➤ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-003	Aug 7, 1987	➤ Sign Up	➤ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-001	Aug 7, 1987	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration